Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$11.78 - $13.86 $294,500 - $346,500
-25,000 Reduced 12.5%
175,000 $2.13 Million
Q2 2023

Aug 14, 2023

SELL
$10.72 - $13.3 $2.95 Million - $3.66 Million
-275,000 Reduced 57.89%
200,000 $2.51 Million
Q1 2023

May 15, 2023

BUY
$10.91 - $13.54 $5.18 Million - $6.43 Million
475,000 New
475,000 $5.27 Million
Q3 2022

Nov 14, 2022

SELL
$9.82 - $12.75 $4.91 Million - $6.38 Million
-500,000 Reduced 50.0%
500,000 $5.22 Million
Q2 2022

Aug 15, 2022

SELL
$6.23 - $11.12 $623,000 - $1.11 Million
-100,000 Reduced 9.09%
1,000,000 $10.7 Million
Q1 2022

May 16, 2022

BUY
$7.89 - $12.48 $4.73 Million - $7.49 Million
600,000 Added 120.0%
1,100,000 $10.4 Million
Q4 2021

Feb 16, 2022

BUY
$9.82 - $12.44 $2.31 Million - $2.92 Million
235,000 Added 88.68%
500,000 $5.78 Million
Q1 2021

May 14, 2021

SELL
$9.2 - $23.86 $3.08 Million - $7.99 Million
-335,000 Reduced 55.83%
265,000 $2.62 Million
Q3 2020

Nov 16, 2020

BUY
$12.89 - $15.89 $7.73 Million - $9.53 Million
600,000 New
600,000 $8.47 Million
Q1 2020

May 15, 2020

SELL
$6.63 - $11.16 $8.29 Million - $14 Million
-1,250,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$7.48 - $10.75 $3.4 Million - $4.89 Million
-455,000 Reduced 26.69%
1,250,000 $12.2 Million
Q3 2019

Nov 14, 2019

BUY
$8.02 - $13.25 $2.05 Million - $3.38 Million
255,000 Added 17.59%
1,705,000 $13.7 Million
Q2 2019

Aug 14, 2019

BUY
$10.96 - $14.4 $1.64 Million - $2.16 Million
150,000 Added 11.54%
1,450,000 $18.1 Million
Q1 2019

May 15, 2019

BUY
$10.04 - $13.92 $6.53 Million - $9.05 Million
650,000 Added 100.0%
1,300,000 $17.7 Million
Q4 2018

Feb 14, 2019

BUY
$8.38 - $13.44 $5.45 Million - $8.74 Million
650,000 New
650,000 $6.23 Million
Q2 2018

Aug 14, 2018

SELL
$13.13 - $17.09 $9.85 Million - $12.8 Million
-750,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$13.76 - $17.12 $10.3 Million - $12.8 Million
750,000 New
750,000 $11.3 Million
Q4 2017

Feb 14, 2018

SELL
$12.51 - $16.24 $2.5 Million - $3.25 Million
-200,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.74 - $15.78 $2.35 Million - $3.16 Million
200,000
200,000 $3.02 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.68B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.